You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Venetoclax with ibrutinib for treating relapsed mantle cell lymphoma [ID3879]
In development
Reference number:
GID-TA10774
Expected publication date: TBC
Project information
Project documents
Documents
Documents created during the development process.
Notes
Note
Back to top